Rvl Pharmaceuticals Plc (RVLP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 26,341 | 40,444 | 8,352 | 99,777 | 109,212 |
| Receivables | 17,572 | 2,133 | 4,190 | 645 | 22,592 |
| Inventories | 838 | 838 | 824 | 1,020 | 16,950 |
| Other current assets | 2,096 | 3,063 | 0 | 134,133 | 0 |
| TOTAL | $59,328 | $59,379 | $23,385 | $249,483 | $161,354 |
| Non-Current Assets | |||||
| PPE Net | 804 | 866 | 851 | 848 | 27,123 |
| Intangibles | 83,057 | 83,057 | 83,057 | 83,057 | 163,979 |
| Other Non-Current Assets | 1,119 | 1,368 | 2,254 | 1,623 | 2,712 |
| TOTAL | $84,980 | $85,291 | $86,162 | $85,528 | $193,814 |
| Total Assets | $144,308 | $144,670 | $109,547 | $335,011 | $355,168 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 1,512 | 2,409 | 29,925 | 214,720 | N/A |
| Accounts payable and accrued liabilities | 4,732 | 3,777 | 4,449 | 1,549 | 4,522 |
| Accrued Expenses | 14,345 | 13,077 | 18,521 | 13,420 | 42,720 |
| Other current liabilities | N/A | N/A | N/A | 34,674 | N/A |
| TOTAL | $21,292 | $20,108 | $53,930 | $265,511 | $48,650 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | 43,800 | 0 | 0 | 219,755 |
| Other Non-Current Liabilities | 8,273 | 3,878 | 702 | 435 | 1,137 |
| TOTAL | $53,533 | $47,829 | $867 | $1,046 | $221,321 |
| Total Liabilities | $74,825 | $67,937 | $54,797 | $266,557 | $269,971 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 83,550 | 83,515 | 83,281 | 62,885 | 62,719 |
| Common Shares | 835 | 833 | 631 | 628 | 627 |
| Retained earnings | -524,351 | -517,530 | -497,808 | -479,949 | -462,222 |
| Other shareholders' equity | 0 | 1,700 | -2,229 | -2,229 | -2,229 |
| TOTAL | $69,483 | $76,733 | $54,750 | $68,454 | $85,197 |
| Total Liabilities And Equity | $144,308 | $144,670 | $109,547 | $335,011 | $355,168 |